StockData
Roivant Sciences Ltd. logo

Roivant Sciences Ltd. (ROIV) bonds

ROIVNasdaqPharmaceutical PreparationsFiscal year ends March 31
Số liệu tài chính tới Q1 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 7/30
$38.71+0.10 (+0.26%)

Close on Nov 17, 2026Market cap $27.96BP/E –Yield –

Debt

Borrowings on the balance sheet, Jun 30, 2026

Roivant Sciences reports no long-term debt line

Its balance sheet in XBRL does not include long-term debt, so totals and interest cost cannot be shown.

When the debt comes due

Principal repayments of long-term debt by fiscal year, as scheduled at Mar 31, 2022

From the debt maturity table in the annual report (filing). “Later” is everything due after year five.

Notes and loans outstanding

As tagged in Roivant Sciences's 10-Q for the period ended Jun 30, 2022

IssueCarrying value
Revenue Interest Purchase And Sale Agreement$161.06M

Companies tag their debt differently: some list every note, others group notes by issuance year or by type, so the list may not add up to total debt. Notes that matured before today are hidden. Source: 10-Q.

Credit facilities

Revolving credit lines and other committed borrowing capacity

FacilitySize
Credit Facility–

See a number that looks wrong?